Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Luo Li

Showing results (111-120 of 121) with videos related to

Pageof 13
Sort By:
Journal of Translational Medicine|July 31, 2024
Targeting tumor-infiltrating CCR8<sup>+</sup> regulatory T cells induces antitumor immunity through functional restoration of CD4<sup>+</sup> T<sub>convs</sub> and CD8<sup>+</sup> T cells in colorectal cancerQian Chen, Meiying Shen, Min Yan, et al.
Frontiers in Immunology|December 24, 2021
A Highly Conserved Peptide Vaccine Candidate Activates Both Humoral and Cellular Immunity Against SARS-CoV-2 Variant StrainsFengxia Gao, Jingjing Huang, Tingting Li, et al.
Cancer Immunology, Immunotherapy : CII|June 4, 2024
Identification of an HLA-A*11:01-restricted neoepitope of mutant PIK3CA and its specific T cell receptors for cancer immunotherapy targeting hotspot driver mutationsMeiying Shen, Siyin Chen, Xiaojian Han, et al.
The Lancet Regional Health. Southeast Asia|November 29, 2023
Towards responsive policy and actions to address non-communicable disease risks amongst adolescents in Indonesia: insights from key stakeholdersKarly I Cini, Nisaa R Wulan, Dorothea Dumuid, et al.
Nature Communications|July 14, 2025
Enhancing the strength and ductility of a medium entropy alloy through non-basal slip activationZhen Chen, Yang Chen, Daixiu Wei, et al.
Genes & Diseases|July 5, 2021
Identification of cross-reactive CD8<sup>+</sup> T cell receptors with high functional avidity to a SARS-CoV-2 immunodominant epitope and its natural mutant variantsChao Hu, Meiying Shen, Xiaojian Han, et al.
Gut|December 17, 2025
PCK1 deficiency promotes MASH-HCC progression by 12-HETE-induced CD8<sup>+</sup> T cell dysfunctionKang Wu, Luo Li, Yi Liu, et al.
Iscience|November 7, 2022
Extended SARS-CoV-2 RBD booster vaccination induces humoral and cellular immune tolerance in miceFeng-Xia Gao, Rui-Xin Wu, Mei-Ying Shen, et al.
Lancet (London, England)|April 21, 2024
Matching actions to needs: shifting policy responses to the changing health needs of Chinese children and adolescentsTian-Jiao Chen, Bin Dong, Yanhui Dong, et al.
Frontiers in Immunology|April 8, 2021
A Rapid and Efficient Screening System for Neutralizing Antibodies and Its Application for SARS-CoV-2Xiaojian Han, Yingming Wang, Shenglong Li, et al.
Pageof 13

Showing results (111-120 of 121) with videos related to

Sort By:
Pageof 13
Journal of Translational Medicine|July 31, 2024
Targeting tumor-infiltrating CCR8<sup>+</sup> regulatory T cells induces antitumor immunity through functional restoration of CD4<sup>+</sup> T<sub>convs</sub> and CD8<sup>+</sup> T cells in colorectal cancerQian Chen, Meiying Shen, Min Yan, et al.
Frontiers in Immunology|December 24, 2021
A Highly Conserved Peptide Vaccine Candidate Activates Both Humoral and Cellular Immunity Against SARS-CoV-2 Variant StrainsFengxia Gao, Jingjing Huang, Tingting Li, et al.
Cancer Immunology, Immunotherapy : CII|June 4, 2024
Identification of an HLA-A*11:01-restricted neoepitope of mutant PIK3CA and its specific T cell receptors for cancer immunotherapy targeting hotspot driver mutationsMeiying Shen, Siyin Chen, Xiaojian Han, et al.
The Lancet Regional Health. Southeast Asia|November 29, 2023
Towards responsive policy and actions to address non-communicable disease risks amongst adolescents in Indonesia: insights from key stakeholdersKarly I Cini, Nisaa R Wulan, Dorothea Dumuid, et al.
Nature Communications|July 14, 2025
Enhancing the strength and ductility of a medium entropy alloy through non-basal slip activationZhen Chen, Yang Chen, Daixiu Wei, et al.
Genes & Diseases|July 5, 2021
Identification of cross-reactive CD8<sup>+</sup> T cell receptors with high functional avidity to a SARS-CoV-2 immunodominant epitope and its natural mutant variantsChao Hu, Meiying Shen, Xiaojian Han, et al.
Gut|December 17, 2025
PCK1 deficiency promotes MASH-HCC progression by 12-HETE-induced CD8<sup>+</sup> T cell dysfunctionKang Wu, Luo Li, Yi Liu, et al.
Iscience|November 7, 2022
Extended SARS-CoV-2 RBD booster vaccination induces humoral and cellular immune tolerance in miceFeng-Xia Gao, Rui-Xin Wu, Mei-Ying Shen, et al.
Lancet (London, England)|April 21, 2024
Matching actions to needs: shifting policy responses to the changing health needs of Chinese children and adolescentsTian-Jiao Chen, Bin Dong, Yanhui Dong, et al.
Frontiers in Immunology|April 8, 2021
A Rapid and Efficient Screening System for Neutralizing Antibodies and Its Application for SARS-CoV-2Xiaojian Han, Yingming Wang, Shenglong Li, et al.
Pageof 13